TG Therapeutics ( (TGTX) ) has released its Q4 earnings. Here is a breakdown of the information TG Therapeutics presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of novel treatments for B-cell diseases, with a focus on multiple sclerosis therapies.